Browsing: March 2021
![CCA-HOT ICU.jpg CCA-HOT ICU.jpg](/siteassets/emresident/images/series/critical-care-alert/cca-hot-icu.jpg)
![PD_Q-and-A_MSC_0816-702x336.jpg PD_Q-and-A_MSC_0816-702x336.jpg](/siteassets/emresident/images/series/pd_q-and-a_msc_0816-702x336.jpg)
![CCA-Receptor Antagonists.jpg CCA-Receptor Antagonists.jpg](/siteassets/emresident/images/series/critical-care-alert/cca-receptor-antagonists.jpg)
![CCA-Tocilizumab.jpg CCA-Tocilizumab.jpg](/siteassets/emresident/images/series/critical-care-alert/cca-tocilizumab.jpg)
![VICTAS.jpg VICTAS.jpg](/siteassets/emresident/images/series/critical-care-alert/victas.jpg)
![hpjc-0321.jpg hpjc-0321.jpg](/siteassets/emresident/images/series/hpjc/hpjc-0321.jpg)
![CCA-beta blockers.png CCA-beta blockers.png](/siteassets/emresident/images/series/critical-care-alert/cca-beta-blockers.png)
Critical Care
,
Critical Care Alert
,
Cardiology
,
Sepsis
The latest EMRA Critical Care Alert examines a study that questions whether ultra-short-acting beta-blockers, such as esmolol and landiolol, reduced 28-day mortality in septic patients with persistent